The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia

BMC Public Health

Volumn 17, Issue 1, 2017, Pages 1-10

  King, Catherine ^a,b   Leask, Julie ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Attitudes; Australia; Communication; Immunisation; Influenza; Parents; Safety; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ADVERSE EFFECTS; ATTITUDE TO HEALTH; CHILD; FEAR; FEMALE; HUMAN; IMMUNIZATION; INFANT; MALE; NEW SOUTH WALES; PARENT; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PSYCHOLOGY; QUALITATIVE RESEARCH; TRUST; VACCINATION;

ADULT; CHILD; CHILD, PRESCHOOL; FEAR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA VACCINES; MALE; NEW SOUTH WALES; PARENTS; QUALITATIVE RESEARCH; TRUST; VACCINATION;

EID: 85010822275     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-017-4032-2     Document Type: Article

References (55)

1. Streefland PH. Public doubts about vaccination safety and resistance against vaccination. Health Policy. 2001;55(3):159-72.
2. Petts J, Niemeyer S. Health risk communication and amplification: learning from the MMR vaccination controversy. Health Risk Soc. 2004;6(1):7-23.
3. Leask J. Target the fence-sitters. Nature. 2011;473(7348):443-5.
4. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32(29):3623-9.
5. Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, Shanman R, Perry T, Goetz MB, Gidengil C. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics. 2014;134(2):325-37.
6. Health and Social Care Information Centre: NHS Immunisation Statistics: England 2013-14. Leeds, UK: Health and Social Care Information Centre; 2014.
7. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 2003;301(5634):804.
8. Miller D, Madge N, Diamond J, Wadsworth J, Ross E. Pertussis immunisation and serious acute neurological illnesses in children. BMJ. 1993;307(6913):1171-6.
9. Begg N, Ramsay M, White J, Bozoky Z. Medicine and the media: media dents confidence in MMR vaccine. BMJ. 1998;316(7130):561.
10. Nicoll A, Elliman D, Ross E. MMR vaccination and autism 1998: deja vu - pertussis and brain damage 1974? BMJ. 1998;316(7133):715-6.
11. Kanai K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Med Sci Biol. 1980;33(3):107-43.
12. Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, Chen RT. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998;351(9099):356-61.
13. Bishop J. Chief Medical Officer. Seasonal flu vaccine and young children [media release]. 2010. [http://www.health.gov.au/internet/main/publishing.nsf/Content/mr-yr10-dept-dept230410.htm]. Accessed 20 Jan 2016.
14. Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children. Australian Government Department of Health and Ageing. 2010. [https://www.tga.gov.au/alert/seasonal-flu-vaccine-overview-vaccine-regulation-and-safety-monitoring-and-investigation-adverse-events-following-2010-seasonal-influenza-vaccination-young-children]. Accessed 19 Jan 2016.
15. Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J. 2008;27(11 Suppl):S149-153.
16. Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26(41):5321-30.
17. Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2012;30(6):1208-24.
18. National Health and Medical Research Council. The Australian Immunisation Handbook 10th ed. Canberra, ACT: Australian Government Department of Health and Ageing; 2013.
19. Australian Government Department of Health. Influenza (Flu). 2016.[http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-influenza]. Accessed 16 Jan 2016.
20. National Centre for Immunisation Research and Surveillance. Pandemic H1N1 2009 influenza vaccine for Australians: information for immunisation providers. 2010. [http://www.ncirs.edu.au/assets/provider_resources/fact-sheets/pH1N1-factsheet.pdf]. Accessed 29 Feb 2016.
21. Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination: status report as at 2 July 2010. 2010. [https://www.tga.gov.au/sites/default/files/alerts-medicine-seasonal-flu-100702.pdf]. Accessed 29 Feb 2016.
22. Bishop J. Chief Medical Officer. Letter to Immunisation Providers. 2010. [https://ama.com.au/sites/default/files/documents/DoHA_Flu_Letter.pdf]. Accessed 20 Jan 2016.
23. King C. Parliamentary Secretary for Health and Ageing. Vaccine side effects under the microscope [media release]. 2011. [http://pandora.nla.gov.au/pan/141595/20130902-0954/www.health.gov.au/internet/ministers/publishing.nsf/Content/DCC3099F4E589F69CA25789A007F6CF2/%24File/ck018.pdf]. Accessed 19 Jan 2016.
24. Horvath J. Review of the management of adverse events associated with Panvax and Fluvax. Australian Government Department of Health and Ageing: Canberra, ACT; 2011.
25. Rockman S, Becher D, Dyson A, Koernig S, Morelli AB, Barnden M, Camuglia S, Soupourmas P, Pearse M, Maraskovsky E. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine. Vaccine. 2014;32(30):3869-76.
26. Kelly HA, Skowronski DM, De Serres G, Effler PV. Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Med J Aust. 2011;195(6):318-20.
27. Li-Kim-Moy J, Booy R. The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010. Influenza Other Respir Viruses. 2016;10(1):9-13.
28. Tickner S, Leman PJ, Woodcock A. Factors underlying suboptimal childhood immunisation. Vaccine. 2006;24(49-50):7030-6.
29. Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015;7.
30. KU Children's Services. 116th Annual report 2011. Sydney: KU Children's Services; 2012.
31. Australian Bureau of Statistics. Socio-economic indexes for areas (SEIFA) - technical paper 2006. Canberra, ACT: Commonwealth Government of Australia; 2008.
32. Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage; 2006.
33. Clarke AE. Situational analysis: grounded theory after the postmodern turn. Thousand Oaks, USA: Sage Publications; 2005.
34. Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, Van Kerkhove MD, Mounts AW, Paget WJ. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10(11):e1001558.
35. Renn O. Risk governance: coping with uncertainty in a complex world. London: Earthscan; 2008.
36. Sandman PM. Responding to community outrage: strategies for effective risk communication. Fairfax, USA: American Industrial Hygiene Association; 1993.
37. Reyna VF. How people make decisions that involve risk: a dual-processes approach. Curr Dir Psychol Sci. 2004;13(2):60-6.
38. Brainerd CJ, Reyna VF. Fuzzy-trace theory and memory development. Dev Rev. 2004;24:396-439.
39. Slovic P, Finucane ML, Peters E, MacGregor DG. Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal. 2004;24(2):311-22.
40. Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14(1):99-117.
41. Serpell L, Green J. Parental decision-making in childhood vaccination. Vaccine. 2006;24(19):4041-6.
42. Lupton DA. 'The best thing for the baby': Mothers' concepts and experiences related to promoting their infants' health and development. Health Risk Soc. 2011;13(7-8):637-51.
43. Lupton D. Risk. London: Routledge; 1999.
44. Giddens A. The consequences of modernity. Stanford, USA: Stanford University Press; 1990.
45. Blyth CC, Richmond PC, Jacoby P, Thornton P, Regan A, Robins C, Kelly H, Smith DW, Effler PV. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. Vaccine. 2014;32(32):4075-81.
46. Velan B. Acceptance on the move: public reaction to shifting vaccination realities. Hum Vaccin. 2011;7(12):1261-70.
47. Walsh S, Thomas DR, Mason BW, Evans MR. The impact of the media on the decision of parents in South Wales to accept measles-mumps-rubella (MMR) immunization. Epidemiol Infect. 2015;143(3):550-60.
48. Leask J, Hooker C, King C. Media coverage of health issues and how to work more effectively with journalists: a qualitative study. BMC Public Health. 2010;10:535.
49. Guillaume LR, Bath PA. The impact of health scares on parents' information needs and preferred information sources: a case study of the MMR vaccine scare. Health Informatics J. 2004;10(1):5-22.
50. Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133(4):e835-842.
51. Parrella A, Gold M, Marshall H, Braunack-Mayer A, Watson M, Baghurst P. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Hum Vaccin Immunother. 2012;8(5):662-7.
52. Mak DB, Carcione D, Joyce S, Tomlin S, Effler PV. Paediatric influenza vaccination program suspension: effect on childhood vaccine uptake. Aust N Z J Public Health. 2012;36(5):494-5.
53. Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Borland ML, Willis GA, Levy A, Keil AD, Richmond PC. Influenza vaccine effectiveness and uptake in children at risk of severe disease. Pediatr Infect Dis J. 2016;35(3):309-15.
54. Covello VT. Best practices in public health risk and crisis communication. J Health Commun. 2003;8 Suppl 1:5-8. discussion 148-151.
55. Cairns G, de Andrade M, MacDonald L. Reputation, relationships, risk communication, and the role of trust in the prevention and control of communicable disease: a review. J Health Commun. 2013;18(12):1550-65.